Allspring Global Investments
SUPN icon

Allspring Global Investments’s Supernus Pharmaceuticals SUPN Stock Holding History

Allspring Global Investments’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$329K Buy
6,390
+649
+11% +$33K ﹤0.01% 1507
2025
Q4 		$284K Buy
+5,741
New +$279K ﹤0.01% 1522
2025
Q2 		– Sell
-19,353
Closed -$613K – 1794
2025
Q1 		$613K Sell
19,353
-1,356
-7% -$48K ﹤0.01% 1388
2024
Q4 		$754K Sell
20,709
-2,996
-13% -$105K ﹤0.01% 1357
2024
Q3 		$739K Sell
23,705
-10,702
-31% -$334K ﹤0.01% 1392
2024
Q2 		$920K Sell
34,407
-1,930
-5% -$55.9K ﹤0.01% 1350
2024
Q1 		$1.24M Sell
36,337
-303
-0.8% -$9.02K ﹤0.01% 1312
2023
Q4 		$1.06M Sell
36,640
-2,943
-7% -$78K ﹤0.01% 1327
2023
Q3 		$1.09M Sell
39,583
-15,596
-28% -$475K ﹤0.01% 1339
2023
Q2 		$1.66M Sell
55,179
-36,691
-40% -$1.28M ﹤0.01% 1291
2023
Q1 		$3.33M Buy
91,870
+30,611
+50% +$1.18M 0.01% 1104
2022
Q4 		$2.19M Buy
61,259
+51,613
+535% +$1.79M ﹤0.01% 1216
2022
Q3 		$326K Buy
9,646
+7,170
+290% +$233K ﹤0.01% 1676
2022
Q2 		$71K Sell
2,476
-59,513
-96% -$1.7M ﹤0.01% 2153
2022
Q1 		$2M Sell
61,989
-3,511
-5% -$108K ﹤0.01% 1498
2021
Q4 		$1.91M Buy
+65,500
New +$1.99M ﹤0.01% 1553

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's SUPN Position: Q1 2026 in Review

Allspring Global Investments increased its Supernus Pharmaceuticals (SUPN) stake by 11% in Q1 2026, buying an estimated $33K and bringing the position to 6,390 shares worth $329K. The position accounts for ﹤0.01% of the portfolio, ranked #1507.

Allspring Global Investments first reported a position in SUPN in Q4 2021 and has held it in 16 quarters since. The position peaked at $3.33M in Q1 2023. 327 funds tracked by Wall St. Rank hold SUPN as of Q1 2026.

  • Allspring Global Investments held 6,390 shares of Supernus Pharmaceuticals worth $329K as of Q1 2026.
  • Allspring Global Investments bought 649 Supernus Pharmaceuticals shares in Q1 2026, an estimated $33K.
  • Supernus Pharmaceuticals made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1507 holding.
  • Allspring Global Investments first reported a position in Supernus Pharmaceuticals in Q4 2021 and has held it in 16 quarters since.
  • Allspring Global Investments's Supernus Pharmaceuticals position peaked at $3.33M in Q1 2023.
  • 327 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.